Pentokey Organy Reports Robust Q2 FY26 Performance with 347% Revenue Growth
Pentokey Organy Limited, operating in the Pharma/Pesticides trading segment, announced impressive Q2 FY26 results. Revenue from operations soared 346.95% to Rs. 98.33 lakhs, while total income rose 195.47% to Rs. 108.94 lakhs. Net profit increased by 35.14% to Rs. 14.23 lakhs, with EPS reaching Rs. 0.23. The company's half-year revenue for FY26 stood at Rs. 604.54 lakhs, up from Rs. 22.09 lakhs in the previous year. An unmodified limited review report was issued by the statutory auditors. The company has a pending income tax appeal for Rs. 171.58 lakhs for the assessment year 2015-16.
*this image is generated using AI for illustrative purposes only.
Pentokey Organy (India) Limited has announced its financial results for the second quarter of fiscal year 2026, showcasing significant growth across key metrics. The company, which operates in the Pharma/Pesticides trading segment, has demonstrated a remarkable turnaround in its performance compared to the same period last year.
Financial Highlights
| Metric | Q2 FY26 | Q2 FY25 | YoY Change |
|---|---|---|---|
| Revenue from Operations | 98.33 | 22.00 | 346.95% |
| Total Income | 108.94 | 36.87 | 195.47% |
| Net Profit | 14.23 | 10.53 | 35.14% |
| Basic EPS | 0.23 | 0.17 | 35.29% |
All financial figures in Rs. lakhs, except EPS
The company's revenue from operations saw a substantial increase of 346.95%, rising to Rs. 98.33 lakhs from Rs. 22.00 lakhs in the corresponding quarter of the previous year. This growth contributed to a total income of Rs. 108.94 lakhs, marking a 195.47% increase from the Rs. 36.87 lakhs reported in Q2 FY25.
Profitability also improved, with Pentokey Organy posting a net profit of Rs. 14.23 lakhs, up 35.14% from Rs. 10.53 lakhs in the same quarter last year. This improvement is reflected in the basic earnings per share, which increased to Rs. 0.23 from Rs. 0.17 year-on-year.
Half-Year Performance
For the first half of FY26, Pentokey Organy reported revenue of Rs. 604.54 lakhs, a significant jump from Rs. 22.09 lakhs in the previous year's corresponding period. This substantial increase indicates a strong recovery and growth trajectory for the company.
Audit Review and Compliance
The financial results were reviewed and approved at a Board meeting held on November 8, 2025. The company's statutory auditors, A Verma Mehta & Associates, Chartered Accountants, have issued an unmodified limited review report on the quarterly financial results. This review was conducted in accordance with the Standard on Review Engagements (SRE) 2410, as issued by the Institute of Chartered Accountants of India.
Ongoing Tax Matter
It's worth noting that Pentokey Organy has an outstanding income tax demand of Rs. 171.58 lakhs for the assessment year 2015-16. The company has filed an appeal against this demand, which is currently pending resolution.
The strong quarterly performance, particularly the significant revenue growth, suggests that Pentokey Organy may be experiencing increased demand for its products or services in the Pharma/Pesticides trading segment. However, investors should consider both the company's growth trajectory and the pending tax matter when evaluating its overall financial position.
Historical Stock Returns for Pentokey Organy
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.99% | +3.18% | +7.64% | +23.13% | +0.57% | +882.67% |
16
